Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early vs delayed intervention in escitalopram non-responders with major depressive disorder
2008-002319-42Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in major depressive disorder (MDD) comparing Early intervention strategy (switch to duloxetine) with Delayed intervention strategy (continued escitalopram) (2 arms). Primary endpoint: Time to confirmed response. Started Aug 2008; status: completed.
02
Drugs
duloxetineescitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2008-002319-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002319-42.